- Home
- FPAY vs COEP Comparison
FPAY vs COEP Comparison
Compare FPAY & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- COEP
- Stock Information
- Founded
- FPAY 2003
- COEP 2017
- Country
- FPAY United States
- COEP United States
- Employees
- FPAY N/A
- COEP N/A
- Industry
- FPAY Diversified Commercial Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FPAY Consumer Discretionary
- COEP Health Care
- Exchange
- FPAY Nasdaq
- COEP Nasdaq
- Market Cap
- FPAY 28.7M
- COEP 27.4M
- IPO Year
- FPAY N/A
- COEP N/A
- Fundamental
- Price
- FPAY $1.10
- COEP $9.14
- Analyst Decision
- FPAY Strong Buy
- COEP
- Analyst Count
- FPAY 2
- COEP 0
- Target Price
- FPAY $3.25
- COEP N/A
- AVG Volume (30 Days)
- FPAY 83.1K
- COEP 34.5K
- Earning Date
- FPAY 08-05-2025
- COEP 08-15-2025
- Dividend Yield
- FPAY N/A
- COEP N/A
- EPS Growth
- FPAY N/A
- COEP N/A
- EPS
- FPAY N/A
- COEP N/A
- Revenue
- FPAY $139,800,732.00
- COEP $62,874.00
- Revenue This Year
- FPAY $16.58
- COEP N/A
- Revenue Next Year
- FPAY N/A
- COEP N/A
- P/E Ratio
- FPAY N/A
- COEP N/A
- Revenue Growth
- FPAY 19.51
- COEP N/A
- 52 Week Low
- FPAY $0.84
- COEP $2.31
- 52 Week High
- FPAY $2.37
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- FPAY 42.13
- COEP 59.60
- Support Level
- FPAY $0.84
- COEP $7.25
- Resistance Level
- FPAY $1.17
- COEP $8.86
- Average True Range (ATR)
- FPAY 0.08
- COEP 0.69
- MACD
- FPAY -0.02
- COEP 0.15
- Stochastic Oscillator
- FPAY 56.52
- COEP 75.48
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.